KAELA SALBER: Open Payments
NPI 1174234611 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 37 payments from 14 companies in 2025. Trend: 2023 $1,174 · 2024 $2,037 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $245 |
| Janssen Scientific Affairs, LLC | 2 | $185 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
| Madrigal Pharmaceuticals | 2 | $58 |
| Janssen Biotech, Inc. | 4 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| GENZYME CORPORATION | 2 | $37 |
| Novo Nordisk Inc | 1 | $29 |
| Ardelyx, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: TREMFYA, DUPIXENT, RINVOQ, LINZESS, REZDIFFRA, TRULANCE, SKYRIZI, Wegovy.
Industry payments across FL — which companies pay providers there.
